Gå direkt till huvudinnehållet

Gynekologiska blödningsrubbningar

Senast uppdaterad: Publicerad:
Sakkunnig:
  1. Munro MG, Critchley HOD, Fraser IS et al. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynecol Obstet 2018; 143: 393-408. pmid:30198563 PubMed  
  2. Knol HM, Mulder AB, Bogchelman DH et al. The prevalence of underlying bleeding disorders in patients with heavy menstrual bleeding with and without gynecologic abnormalities. Am J Obstet Gynecol. 2013;209:202.e1-7. PMID: 23727521. PubMed  
  3. Eraker R, Gravdal LC. Veileder i gynekologi. Gynekologiske blødningsforstyrrelser. Sist rev. 2015.
  4. Sweet MG, Schmidt-Dalton TA, Weiss PM. Evaluation and management of abnormal uterine bleeding in premenopausal women. Am Fam Physician 2012; 85: 35-43. pmid: 22230306 PubMed  
  5. Jacobson AE, Vesely SK, Koch T, et al. Patterns of von Willebrand Disease Screening in Girls and Adolescents With Heavy Menstrual Bleeding. Obstet Gynecol 2018. pmid:29742662 PubMed  
  6. Stewart EA. Uterine adenomyosis. UpToDate, last updated Oct 2019. www.uptodate.com  
  7. Pickett CA. Diagnosis and management of pituitary tumors: recent advances. Prim Care 2003; 30: 765-89. PubMed  
  8. Warner PE, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray GD. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. Am J Obstet Gynecol 2004; 190: 1216-23. PubMed  
  9. National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management. NICE guideline NG88. Published date: March 2018 Last updated: November 2018. Cited Dec 2019. www.nice.org.uk  
  10. Pickett CA. Diagnosis and management of pituitary tumors: recent advances. Prim Care. 2003;30(4):765–789. www.ncbi.nlm.nih.gov  
  11. Kalro B. Impaired fertility caused by endocrine dysfunction in women. Endocrinol Metab Clin North Am 2003; 32: 573-92. PubMed  
  12. Arojoki M, Jokimaa V, Juuti A, Koshinen P, Irajala K, Anttila L. Hypothyroidism among infertile women in Finland. Gynecol Endocrinol 2000; 14: 127-31. PubMed  
  13. Warren MP, Biller BM, Shangold MM. A new clinical option for hormone replacement therapy in women with secondary amenorrhea: effects of cyclic administration of progesterone from the sustained-release vaginal gel Crinone (4% and 8%) on endometrial morphologic features and withdrawal bleeding. Am J Obstet Gynecol 1999; 180: 42-8. PubMed  
  14. Farquhar C, Ekeroma A, Furness S, Arroll B. A systematic review of transvaginal ultrasonography, sonohysterography and hysteroscopy for the investigation of abnormal uterine bleeding in premenopausal women. Acta Obstet Gynecol Scand. 2003 Jun;82(6):493-504. PMID: 12780419. PubMed  
  15. Lethaby A, Wise MR, Weterings MAJ et al. Combined hormonal contraceptives for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2019, Issue 2. Art. No.: CD000154. DOI: 10.1002/14651858.CD000154.pub3. The Cochrane Library  
  16. Heliovaara-Peippo S, Hurskainen R, Teperi J, et al. Quality of life and costs of levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of menorrhagia: a 10-year randomized controlled trial. Am J Obstet Gynecol 2013 Dec;209(6):535.e1-535.e14.
  17. Bofill Rodriguez M, Lethaby A, Jordan V. Progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev. 2020 Jun 12;6:CD002126. doi: 10.1002/14651858.CD002126.pub4. DOI  
  18. Kaunitz AM, Bissonnette F, Monteiro I, et al. Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol 2010; 116: 625-32. PubMed  
  19. Gupta J, Kai J, Middleton L, et al. Levonorgestrel intrauterine system versus medical therapy for menorrhagia. N Engl J Med 2013; 368: 128-37. New England Journal of Medicine  
  20. Bofill Rodriguez M, Lethaby A, Low C, Cameron IT. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2019, Issue 8. Art. No.: CD001016. DOI: 10.1002/14651858.CD001016.pub3 DOI  
  21. Wouk N, Helton M. Abnormal Uterine Bleeding in Premenopausal Women. Am Fam Phys 2019; 99: 435-43. pmid:30932448 PubMed  
  22. Bryant‐Smith AC, Lethaby A, Farquhar C, Hickey M. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2018, Issue 4. Art. No.: CD000249. PMID: 29656433 PubMed  
  23. Bofill Rodriguez M, Lethaby A, Farquhar C. Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2019, Issue 9. Art. No.: CD000400. PMID: 31535715 PubMed  
  24. Kuppermann M, Varner RE, Summitt RL, et al. Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning. The medicine or surgery (Ms) randomized trial. JAMA 2004; 291:1447-455. Journal of the American Medical Association  
  25. Bofill Rodriguez M, Lethaby A, Grigore M, Brown J, Hickey M, Farquhar C. Endometrial resection and ablation techniques for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2019, Issue 1. Art. No.: CD001501. PMID: 31463964 PubMed  
  26. Sambrook AM, Elders A, Cooper KG. Microwave endometrial ablation versus thermal balloon endometrial ablation (MEATBall): 5-year follow up of a randomised controlled trial. BJOG 2014. pmid: 24506529 PubMed  
  27. Fergusson RJ, Lethaby A, Shepperd S, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD000329.pub2. The Cochrane Library  
  28. Middleton LJ, Champaneria R, Daniels JP, et al. Hysterectomi, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients. BMJ 2010; 341: c3771. pmid: 20713583 PubMed  
  29. Regionalt vårdprogram för hypofystumörer Uppsala-Örebro sjukvårdsregion. 2019-09-15 Version: 04 www.cancercentrum.se  
  • Barbro Larson, docent och specialist i gynekologi och obstetrik, Stockholm
  • Anna Nager, docent och specialist i allmänmedicin, Karolinska institutet

Tidigare sakkunniga

  • Silje Folven Barlindhaug, spesialist i allmennmedisin, redaktør NEL